Exicure, Inc. (XCUR)
Nasdaq: XCUR · Pharmaceutical Preparations · Chicago, IL · filing with the SEC since 2017
Who owns Exicure, Inc.
As filed with the SECHolders of 5% or more
1
Exicure HiTron Inc. holds 34.9% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13D/A filed Jul 17, 2026 says.
Directors and officers
3
report now, of 42 people on the record since 2017. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Exicure HiTron Inc.
SCHEDULE 13D/A · filed Jul 17, 2026 · Common Stock, par value $0.0001 per share · 25.1% in Jan 21, 2026
Sangsangin Investment & Securities Co., Ltd.
SCHEDULE 13G/A · filed Dec 10, 2025 · Common Stock, par value $0.0001 per share (the "Common Stock") · reported falling below 5%, from 14.3% in Dec 23, 2024
What XCUR reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Gpcr Usa
A company bought · acquisition · Jan 2025 · owns, named in the 10-K filed Mar 25, 2026
1 subsidiary in 1 country, from the list filed with the 10-K/A filed May 1, 2023.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2022 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 49 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Hitron Systems Inc. | 10% owner | 3 | $7.8M | 0 | 0 | $0 |
| Sangsangin Investment & Securities Co., Ltd. | 10% owner | 1 | $3.8M | 0 | 0 | $0 |